Literature DB >> 27572522

Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis.

Patompong Ungprasert1, Matthew J Koster2, Charat Thongprayoon3, Kenneth J Warrington2.   

Abstract

To investigate the possible association between systemic vasculitis and risk of venous thromboembolism (VTE), two investigators independently searched published studies indexed in MEDLINE, EMBASE, and the Cochrane database from inception to April 2016 using the terms for each type of vasculitis in conjunction with the terms for venous thromboembolism. The inclusion criteria were as follows: (1) observational studies published as original studies to evaluate the association between vasculitis and VTE, (2) odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 % confidence intervals (CI) were provided, and (3) participants without vasculitis were used as comparators for cohort studies and cross-sectional studies while participants without VTE were used as comparators for case-control studies. RevMan 5.3 software was used for the data analysis. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Seven studies investigating the risk of VTE among patients with systemic vasculitis were identified. At least one study was available for three specific forms of vasculitis (polyarteritis nodosa [PAN], granulomatosis with polyangiitis [GPA], and giant cell arteritis [GCA]). An increased risk of VTE was seen in all three vasculitides (GPA, pooled RR 3.94, 95 % CI 1.11-14.01; PAN, pooled RR 3.00, 95 % CI 2.20-4.09; GCA, pooled RR 2.26, 95 % CI 1.38-3.71). This meta-analysis demonstrates that patients with systemic vasculitis may have a significantly increased risk of VTE.

Entities:  

Keywords:  Epidemiology; Meta-analysis; Thromboembolism; Vasculitis

Mesh:

Year:  2016        PMID: 27572522     DOI: 10.1007/s10067-016-3394-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  Risk of venous thromboembolism in first- and second-generation immigrants in Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Eur J Intern Med       Date:  2011-08-23       Impact factor: 4.487

2.  The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.

Authors:  J Antonio Aviña-Zubieta; Vidula M Bhole; Neda Amiri; Eric C Sayre; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-09-29       Impact factor: 19.103

3.  Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Authors:  Hussain R Yusuf; W Craig Hooper; Scott D Grosse; Christopher S Parker; Sheree L Boulet; Thomas L Ortel
Journal:  Thromb Res       Date:  2014-10-22       Impact factor: 3.944

4.  Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis.

Authors:  G Espinosa; D Tàssies; J Font; F J Muñoz-Rodríguez; R Cervera; A Ordinas; J C Reverter; M Ingelmo
Journal:  Semin Arthritis Rheum       Date:  2001-08       Impact factor: 5.532

5.  [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica].

Authors:  C Hulin; E Hachulla; U Michon-Pasturel; P Y Hatron; E Masy; J M Gillot; C Caron; J Arvieux; R M Flipo; B Devulder
Journal:  Rev Med Interne       Date:  1999-08       Impact factor: 0.728

Review 6.  Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Anawin Sanguankeo
Journal:  Rheumatol Int       Date:  2014-04-20       Impact factor: 2.631

7.  Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism.

Authors:  Frederick A Anderson; Maxim Zayaruzny; John A Heit; Dogan Fidan; Alexander T Cohen
Journal:  Am J Hematol       Date:  2007-09       Impact factor: 10.047

8.  High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.

Authors:  Tamihiro Kawakami; Masahide Yamazaki; Masako Mizoguchi; Yoshinao Soma
Journal:  Arthritis Rheum       Date:  2007-12-15

9.  Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study.

Authors:  Sreeram V Ramagopalan; Clare J Wotton; Adam E Handel; David Yeates; Michael J Goldacre
Journal:  BMC Med       Date:  2011-01-10       Impact factor: 8.775

Review 10.  Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review.

Authors:  Raúl Herzog; María José Álvarez-Pasquin; Camino Díaz; José Luis Del Barrio; José Manuel Estrada; Ángel Gil
Journal:  BMC Public Health       Date:  2013-02-19       Impact factor: 3.295

View more
  6 in total

Review 1.  Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa.

Authors:  Alojzija Hočevar; Matija Tomšič; Katja Perdan Pirkmajer
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

2.  Letter to the Editor: "Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis".

Authors:  Andreas Kronbichler; Jae Il Shin
Journal:  Clin Rheumatol       Date:  2016-09-22       Impact factor: 2.980

Review 3.  Narrative Review of Hypercoagulability in Small-Vessel Vasculitis.

Authors:  Sophie E Claudel; Bryan M Tucker; Daniel T Kleven; James L Pirkle; Mariana Murea
Journal:  Kidney Int Rep       Date:  2020-01-13

Review 4.  Role of von Willebrand factor in venous thromboembolic disease.

Authors:  Alison Michels; David Lillicrap; Michael Yacob
Journal:  JVS Vasc Sci       Date:  2021-10-07

5.  Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: A population-based study.

Authors:  Shelby Marozoff; Alice Mai; Natasha Dehghan; Eric C Sayre; Hyon K Choi; J Antonio Aviña-Zubieta
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

6.  Epidemiology of venous thromboembolism in Africa: a systematic review and meta-analysis protocol.

Authors:  Celestin Danwang; Mazou N Temgoua; Valirie Ndip Agbor; Aurel T Tankeu; Jean Jacques Noubiap
Journal:  BMJ Open       Date:  2017-10-10       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.